Survivin - An attractive target for RNAi in non-Hodgkin's lymphoma, Daudi cell line as a model

Leukemia and Lymphoma

Volumn 47, Issue 9, 2006, Pages 1941-1948

  Congmin, Gu ^a   Mu, Zeng ^b   Yihui, Ma ^c   Hanliang, Lin ^d  

^a Guangzhou Women and Children Hospital ^*  (China)

^b JINAN UNIVERSITY   (China)

^c HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Daudi; Non Hodgkin's lymphoma; Short hairpin RNA; Survivin

Indexed keywords

SHORT HAIRPIN RNA; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DAUDI CELL; DRUG TARGETING; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BURKITT LYMPHOMA; CELL PROLIFERATION; FLOW CYTOMETRY; GENE SILENCING; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33750440217     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600725354     Document Type: Article

References (28)

1. Amborosini, G and Adida, C and Altieri, D. (1997) A novel anti-apopotsis gene, survivin, expressed in cancer and lymphoma Nat Med, 3, pp. 917-921.
2. Tamm, I and Wang, Y and Sausville, E and Scudiero, D and Vigna, N and Oltersdorf, T and Reed, J. (1998) IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res, 58(23), pp. 5315-5320.
3. Li, F and Ambrosini, G and Chu, E and Plescia, J and Tognin, S and Marchisio, P and Altieri, D. (1998) Control of apoptosis and mitotic spindle checkpoint by Survivin Nature, 396(6711), pp. 580-584.
4. Monzo, M and Rosell, R and Felip, E and Astudillo, J and Sanchez, J and Maestre, J and (1999) A novel anti-apoptosis gene: Re-expression of Survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J Clin Oncol, 17(7), pp. 2100-2104.
5. Swana, H and Grossman, D and Anthony, J and Weiss, R and Altieri, D. (1999) Tumor content of the antiapoptosis molecule Survivin and recurrence of bladder cancer N Engl J Med, 341(6), pp. 452-453.
6. Jacobson, J and Wilkes, B and Kwaiatkowski, D and Medeiros, L and Aisenberg, A and Harris, N. (1993) Bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features Cancer, 72, pp. 231-236.
7. Dierlamm, J and Baens, M and Wlodarska, I and Stefanova-Ouzounova, M and Hernandez, J and Hossfeld, D and (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t (11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas Blood, 93, pp. 3601-3609.
8. Adida, C and Haioun, C and Gaulard, P and Lepage, E and Morel, P and Briere, J and (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas Blood, 96(5), pp. 1921-1925.
9. Ansell, S and Arendt, B and Grote, D and Jelinek, D and Novak, A and Wellik, L and (2004) Inhibition of Survivin expression surppresses the growth of aggressive non-Hodgkin's lymphoma Leukemia, 18(3), pp. 616-623.
10. Izquierdo, M. (2005) Short interfering RNAs as a tool for cancer gene therapy Cancer Gene Ther, 12, pp. 217-227.
11. Olie, R and Simões-Wüst, A and Baumann, B and Leech, S and Fabbro, D and Stahel, R and Zangemeister-Wittke, U. (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy Cancer Res, 60, pp. 2805-2809.
12. Ambrosini, G and Adida, C and Sirugo, G and Altireri, D. (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting J Biol Chem, 273, pp. 11177-11182.
13. Mesri, M and Wall, N and Li, J and Kim, R and Altieri, D. (2001) Cancer gene therapy using a survivin mutant adneovirus J Clin Invest, 108, pp. 981-990.
14. Pennati, M and Colella, G and Folini, M and Citti, L and Daidone, M and Zaffaroni, N. (2002) Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis J Clin Invest, 109, pp. 285-286.
15. Pennati, M and Campbell, A and Curto, M and Binda, M and Cheng, Y and Wang, L and (2005) Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: A possible role for survivin down-regulation Mol Cancer Ther, 4(9), pp. 1328-1337.
16. Carvalho, A and Carmena, M and Sambade, C and Earnshaw, W and Wheatley, S. (2003) Survivin is required for stable checkpoint activation in taxol-treated HeLa cells J Cell Sci, 116, pp. 2987-2998.
17. Paddison, P and Caudy, A and Bernstein, E and Hannon, G and Conklin, D. (2002) Short hairpin RNAs (shRNA) induce sequence-specific silencing in mammalian cells Genes Dev, 16, pp. 948-958.
18. Brummelkamp, T and Bernards, R and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells Science, 296, pp. 550-553.
19. Xiang, L and Fengzhi, L. (2004) Silencing of antiapoptotic Survivin gene by multiple approaches of RNA interference technology BioTechniques, 36, pp. 450-460.
20. Czauderna, F and Fechtner, M and Aygun, H and Amold, W and Kippel, A and Giese, K and Kaufmann, J. (2003) Functional studies of the PI(3)-kinase signaling pathway employing synthetic and expressed shRNA Nucleic Acid Res, 31, pp. 670-682.
21. Cheng, S and Wang, W and Yan, W and Li, Q and Wang, L and Wang, W. (2005) Knockdown of Survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721 World J Gastroenterol, 11(5), pp. 756-769.
22. Carvalho, A and Carmena, M and Sambade, C and Earnshaw, W and Wheatley, S. (2003) Survivin is required for stable checkpoint activation in taxol-treated HeLa cells J Cell Sci, 116(Pt 14), pp. 2987-2998.
23. Williams, N and Gaynor, R and Scoggin, S and Verma, U and Gokaslan, T and Simmang, C and (2003) Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference Clin Cancer Res, 9(3), pp. 931-946.
24. Wang, Y and Zhu, H and Quan, L and Zhou, C and Bai, J and Zhang, G and (2005) Downregulation of Survivin by RNAi inhibits the growth of esophageal carcinoma cells Cancer Biol Ther, 4(9), pp. 974-978.
25. Chawla-Sarkar, M and Bae, S and Reu, F and Jacobes, B and Lindner, D and Borden, E. (2004) Downregulation of Bcl-2, FLIP or IAPs (XIAP and Survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/ TRAIL-induced apoptosis Cell Death Differ, 11(8), pp. 915-923.
26. Kappler, M and Bache, M and Bartel, F and Kotzsch, M and Panian, M and Wurl, P and (2004) Knockdown of Survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53 Cancer Gene Ther, 11(3), pp. 186-193.
27. Kappler, M and Taubert, H and Bartel, F and Blumke, K and Panian, M and Schmidt, H and (2005) Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wtp53 sarcoma cell line, but not in a mt-p53 sarcoma cell line Oncol Rep, 13, pp. 167-172.
28. Mazur, G and Halon, A and Wrobel, T and Urbaniak, J and Kuliczkowski, K and Wozniak, M. (2004) Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasia Rocz Akad Med Bialymst, 49(Suppl 1), pp. 76-78.